<DOC>
	<DOCNO>NCT01057927</DOCNO>
	<brief_summary>The purpose study investigate clinical effect multiple ( 28 day ) twice-daily dos OC000459 comparison placebo clinic lung function ( FEV1 ) mild moderate asthmatic FEV1 60-80 % predict require short act inhaled B2-adrenergic agonist symptomatic control .</brief_summary>
	<brief_title>Safety Efficacy Study OC000459 Dosed Twice Daily 28 Days Asthmatic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Indoleacetic Acids</mesh_term>
	<criteria>Inclusion Criteria At Screening : Male female asthmatic , racial group . Females childbearing potential must practise two form contraception Non smoker Mild moderate asthmatic accord GINA guideline least 12 month . History asthma symptom increase response external allergen . Testing positive skin prick test allergen associate subject 's asthma Use inhale local corticosteroid period 28 day prior screen . Receipt prescribe counter medication within 14 day first study day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>